Evidence map›Paper›PMID 41511647›Full record

ArticleMolecular biology reports2026

Correction: Connexin 43 inhibitors reduce cell viability in glioblastoma and astrocyte co-culture systems.

Ali Genc, Berfin Uzunkaya, Gizem InetasYengin, Didem Tecimel, Altay Burak Dalan, Omer Faruk Bayrak

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Ali GencDepartment of Neurosurgery, Iskenderun State Hospital, Hatay, 31240, Turkey.ORCID http://orcid.org/0000-0003-0058-239X
Berfin UzunkayaDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul, 34755, Turkey.ORCID http://orcid.org/0000-0001-7999-7680
Gizem InetasYenginDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul, 34755, Turkey.ORCID http://orcid.org/0000-0002-9421-651X
Didem TecimelDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul, 34755, Turkey.ORCID http://orcid.org/0000-0002-0776-1238
Altay Burak DalanDepartment of Medical Biochemistry, Medical School, Yeditepe University, Istanbul, 34755, Turkey.ORCID http://orcid.org/0000-0002-5644-5725
Omer Faruk BayrakDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul, 34755, Turkey. ofbayrak@yeditepe.edu.tr.ORCID http://orcid.org/0000-0001-7562-6604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.